Equities

Sera Prognostics Inc

SERA:NMQ

Sera Prognostics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.44
  • Today's Change-0.10 / -1.53%
  • Shares traded28.98k
  • 1 Year change+214.15%
  • Beta0.9482
Data delayed at least 15 minutes, as of Nov 25 2024 17:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

  • Revenue in USD (TTM)94.00k
  • Net income in USD-32.24m
  • Incorporated2008
  • Employees57.00
  • Location
    Sera Prognostics Inc2749 E. Parleys Way, Suite 200SALT LAKE CITY 84109United StatesUSA
  • Phone+1 (801) 505-0278
  • Fax+1 (302) 655-5049
  • Websitehttps://www.seraprognostics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Multiplan Corp942.61m-1.54bn112.23m2.80k--0.5407--0.1191-95.37-95.3758.3312.840.1523--12.45336,647.80-24.87---25.65--74.23---163.30----0.40180.9561---10.95--83.99------
Kewaunee Scientific Corporation202.31m18.47m125.50m1.01k7.012.245.700.62036.236.2368.3819.511.587.234.70201,102.4014.621.1821.671.8326.0117.959.280.69692.009.260.356920.85-7.176.812,441.0663.520.7483--
Global Leaders Corp49.36k-87.59k154.39m--------3,127.93-0.0006-0.00060.0003-0.00053.88-------689.14------29.86---177.45---------------372.51------
R C M Technologies Inc272.50m15.72m163.49m3.49k11.035.449.510.6001.951.9533.963.952.40--3.6578,079.0913.8610.3030.2816.5529.3027.465.774.02--11.130.51930.00-7.535.61-19.4337.5814.06--
TSS Inc122.53m4.40m166.07m81.0036.9721.2734.121.360.19990.19995.590.34752.1929.2717.181,512,679.007.86-0.997147.41-3.4115.0220.883.59-0.57330.98813.230.00--77.5619.49201.37-50.291.21--
Mastech Digital Inc194.25m-2.25m177.11m1.40k--2.05132.570.9118-0.2024-0.202416.487.391.76--5.86139,046.50-2.036.76-2.518.5326.8925.94-1.163.30----0.00---16.982.57-181.93---15.36--
Paysign Inc56.47m8.07m185.28m123.0023.346.5013.693.280.14830.14831.020.53260.406--2.82459,086.205.800.759530.843.3753.3750.9014.281.77----0.000.0024.3015.08528.4220.0734.61--
Zeuus Inc0.00-851.79k211.03m-----------0.0081-0.00810.00-0.0160.00-------94.10-72.78-----------18,791.29---4.77--------5.26------
Trueblue Inc1.67bn-116.59m211.05m5.00k--0.6438--0.1261-3.84-3.8454.7711.092.07--6.67334,722.20-14.420.591-18.470.772525.8225.93-6.970.29----0.000.00-15.44-5.27-122.76--12.90--
Hirequest Inc36.28m2.07m214.82m139.00102.923.4044.235.920.14840.1052.624.480.349--0.7208261,000.001.9910.323.0414.51----5.7029.00--25.320.17831.7622.39-17.21-46.2645.8725.21--
Sera Prognostics Inc94.00k-32.24m220.87m57.00--4.04--2,349.70-0.9919-0.99190.00291.620.0011--0.80341,649.12-38.15---49.10--21.28---34,302.13------0.0056--14.18--17.98------
Performant Financial Corp120.78m-8.14m248.18m958.00--3.24--2.05-0.1055-0.10551.570.97811.19--4.98126,077.20-8.04-10.44-9.25-13.50-----6.74-9.97---5.240.0961--4.18-6.08-15.02---11.53--
Resources Connection Inc599.57m12.21m281.49m3.38k23.470.691313.750.46950.35840.358417.7712.171.16--5.04177,596.902.367.452.799.1938.2039.272.045.53----0.0046.98-18.42-2.79-61.31-7.74-30.191.89
Ambipar Emergency Response482.88m12.68m282.14m7.09k22.251.234.130.58430.22880.22888.714.130.6352.903.7168,116.923.60--4.61--18.85--5.72--2.214.390.5904--53.72---138.69------
Data as of Nov 25 2024. Currency figures normalised to Sera Prognostics Inc's reporting currency: US Dollar USD

Institutional shareholders

44.52%Per cent of shares held by top holders
HolderShares% Held
Baker Bros. Advisors LPas of 30 Sep 20245.43m16.77%
RA Capital Management LPas of 30 Sep 20243.03m9.36%
BlackRock Fund Advisorsas of 30 Sep 20241.40m4.33%
The Vanguard Group, Inc.as of 30 Sep 20241.14m3.53%
JPMorgan Investment Management, Inc.as of 30 Sep 2024807.06k2.49%
Invesco Capital Management LLCas of 30 Sep 2024592.20k1.83%
Geode Capital Management LLCas of 30 Sep 2024586.84k1.81%
AWM Investment Co., Inc.as of 30 Sep 2024521.31k1.61%
CapFinancial Partners LLCas of 30 Sep 2024477.22k1.47%
SSgA Funds Management, Inc.as of 30 Sep 2024425.09k1.31%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.